Dr Gail Miflin has been appointed as Medical and Research Director at NHS Blood and Transplant. She will take up the post on June 1.
Dr Miflin qualified from Cambridge University and trained in haematology in Nottingham and Yorkshire She joined NHS Blood and Transplant in 2010 having previously worked as a Consultant Haematologist at the Royal Free Hospital and then UCLH Foundation Trust where she specialised in treating patients with red cell disorders. During this time she worked for three years at South East London Strategic Health Authority – alongside her clinical career – where she gained experience in management and leadership.
Since 2012 she has been an Associate Medical Director at NHS Blood and Transplant. In her current role she has worked closely with the University of Cambridge to establish the National Institute of Health Research (NIHR) Blood and Transplant Research Unit in Donor Health and Genomics.
In her new role she will lead the Clinical Directorate and will be responsible for the Governance framework and clinical governance systems across NHS Blood and Transplant. She will also oversee research and development, acting as the interface with research bodies, including universities and Public Health England. In doing this she will ensure evidence is provided to shape national and international health care policy in respect of transfusion and transplantation medicine and science.
Dr Miflin said, “I feel enormously privileged to be taking on this role. I am looking forward to working with a great team to do what we do best – saving and improving lives by providing a safe supply of blood, organs and tissues. We already work to the highest clinical standards and I will build on these wherever possible. Delivering a world class Research and Development programme that improves patient outcomes is equally important to me.”
Welcoming the appointment, NHS Blood and Transplant Chief Executive Ian Trenholm, said: "I am delighted to appoint Gail to this key role in our organisation. Patient and donor safety is a key priority for us. Ensuring patients have confidence in the blood, organs and tissues they receive through us is vital, as well as ensuring the wellbeing of our donors who make our life saving and enhancing work possible. In addition, Gail will lead our clinical and research response to the opportunities provided by new therapies and help us establish our role in the exciting fields of cellular and regenerative medicine.”
Dr Miflin replaces Dr Lorna Williamson, who retires on May 31.
Source: NHS Blood and Transplant